Hippo Pathway-independent Restriction of TAZ and YAP by Angiomotin
Open Access
- 1 March 2011
- journal article
- Published by Elsevier BV in Journal of Biological Chemistry
- Vol. 286 (9), 7018-7026
- https://doi.org/10.1074/jbc.c110.212621
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- The Hippo Tumor Pathway Promotes TAZ Degradation by Phosphorylating a Phosphodegron and Recruiting the SCFβ-TrCP E3 LigaseJournal of Biological Chemistry, 2010
- WW domain-mediated interaction with Wbp2 is important for the oncogenic property of TAZOncogene, 2010
- The Hippo Signaling Pathway in Development and CancerDevelopmental Cell, 2010
- The Hippo–YAP pathway in organ size control and tumorigenesis: an updated versionGenes & Development, 2010
- Structural basis of YAP recognition by TEAD4 in the Hippo pathwayGenes & Development, 2010
- A coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCFβ-TRCPGenes & Development, 2010
- TEADs Mediate Nuclear Retention of TAZ to Promote Oncogenic TransformationJournal of Biological Chemistry, 2009
- TEAD Transcription Factors Mediate the Function of TAZ in Cell Growth and Epithelial-Mesenchymal TransitionJournal of Biological Chemistry, 2009
- TEAD mediates YAP-dependent gene induction and growth controlGenes & Development, 2008
- Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth controlGenes & Development, 2007